hBD-1 vs Ibutamoren

Head-to-head comparison of hBD-1 (Human beta-defensin 1) and Ibutamoren (Ibutamoren mesylate (MK-677)) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyhBD-1Ibutamoren
CategoryDental & OralGrowth Hormone
Full NameHuman beta-defensin 1Ibutamoren mesylate (MK-677)
Molecular Weight4490 DaN/A
Half-Lifeminutes to hoursabout 24 hours
Amino Acids36N/A
Typical Dose1-10 µg/mL in experimental studies10-25 mg/day
RouteTopical/IntraoralOral
Purity≥98%≥98%
Studies Count85180
Research StatusPre-clinicalClinical

hBD-1 Benefits

  • oral innate immunity
  • broad antimicrobial activity
  • biofilm suppression
  • periodontal support

Ibutamoren Benefits

  • raises GH/IGF-1
  • increases appetite
  • supports lean mass retention
  • oral non-peptide secretagogue

hBD-1 Dosing

topical peptide exposure|cell-culture or mucosal models|repeat low-dose application in research

Ibutamoren Dosing

10-25 mg orally once daily|take consistently at the same time each day|monitor fasting glucose and edema in longer studies

hBD-1 Side Effects

  • protease degradation
  • local irritation at high dose
  • limited stability in saliva

Ibutamoren Side Effects

  • increased appetite
  • water retention/edema
  • somnolence or lethargy

Research Overview

hBD-1

hBD-1 has been studied as part of the oral mucosal defense system and is linked to host resistance against dental pathogens. Research spans periodontitis, candidiasis, and epithelial barrier biology.

Ibutamoren

Clinical studies show oral ibutamoren reliably elevates GH and IGF-1 over 24 hours with once-daily dosing. Body composition and appetite effects vary by population, and development has been limited by metabolic side effects.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

hBD-1 stacks with:

fluoridexylitoloral-probiotics

Ibutamoren stacks with:

Resistance trainingHigh-protein diet
defensinoral-immunityantimicrobial-peptideepithelial-defenseghrelin-receptor-agonistgh-secretagogueoral